These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 33835029)
21. HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells. Chavez L; Calvanese V; Verdin E PLoS Pathog; 2015 Jun; 11(6):e1004955. PubMed ID: 26067822 [TBL] [Abstract][Full Text] [Related]
22. Experimental approaches to the study of HIV-1 latency. Han Y; Wind-Rotolo M; Yang HC; Siliciano JD; Siliciano RF Nat Rev Microbiol; 2007 Feb; 5(2):95-106. PubMed ID: 17224919 [TBL] [Abstract][Full Text] [Related]
23. Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro. Zerbato JM; Serrao E; Lenzi G; Kim B; Ambrose Z; Watkins SC; Engelman AN; Sluis-Cremer N J Virol; 2016 Sep; 90(18):8059-73. PubMed ID: 27356901 [TBL] [Abstract][Full Text] [Related]
24. Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, Uganda. Prodger JL; Lai J; Reynolds SJ; Keruly JC; Moore RD; Kasule J; Kityamuweesi T; Buule P; Serwadda D; Nason M; Capoferri AA; Porcella SF; Siliciano RF; Redd AD; Siliciano JD; Quinn TC Clin Infect Dis; 2017 Oct; 65(8):1308-1315. PubMed ID: 28535179 [TBL] [Abstract][Full Text] [Related]
25. The Oncolytic Virus MG1 Targets and Eliminates Cells Latently Infected With HIV-1: Implications for an HIV Cure. Ranganath N; Sandstrom TS; Burke Schinkel SC; Côté SC; Angel JB J Infect Dis; 2018 Feb; 217(5):721-730. PubMed ID: 29228368 [TBL] [Abstract][Full Text] [Related]
26. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. Siliciano JD; Siliciano RF Methods Mol Biol; 2005; 304():3-15. PubMed ID: 16061962 [TBL] [Abstract][Full Text] [Related]
27. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Pierson T; McArthur J; Siliciano RF Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072 [TBL] [Abstract][Full Text] [Related]
28. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy. Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056 [TBL] [Abstract][Full Text] [Related]
29. Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4 Battivelli E; Dahabieh MS; Abdel-Mohsen M; Svensson JP; Tojal Da Silva I; Cohn LB; Gramatica A; Deeks S; Greene WC; Pillai SK; Verdin E Elife; 2018 May; 7():. PubMed ID: 29714165 [TBL] [Abstract][Full Text] [Related]
30. Selective cell death of latently HIV-infected CD4 Zhang G; Luk BT; Wei X; Campbell GR; Fang RH; Zhang L; Spector SA Cell Death Dis; 2019 May; 10(6):419. PubMed ID: 31142734 [TBL] [Abstract][Full Text] [Related]
31. HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells. Chan CN; Trinité B; Lee CS; Mahajan S; Anand A; Wodarz D; Sabbaj S; Bansal A; Goepfert PA; Levy DN Retrovirology; 2016 Jan; 13():1. PubMed ID: 26728316 [TBL] [Abstract][Full Text] [Related]
32. Dynamics of HIV latency and reactivation in a primary CD4+ T cell model. Mohammadi P; di Iulio J; Muñoz M; Martinez R; Bartha I; Cavassini M; Thorball C; Fellay J; Beerenwinkel N; Ciuffi A; Telenti A PLoS Pathog; 2014 May; 10(5):e1004156. PubMed ID: 24875931 [TBL] [Abstract][Full Text] [Related]
33. Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus. Macedo AB; Resop RS; Martins LJ; Szaniawski MA; Sorensen ES; Spivak AM; Nixon DF; Jones RB; Planelles V; Bosque A AIDS Res Hum Retroviruses; 2018 Sep; 34(9):769-777. PubMed ID: 29926732 [TBL] [Abstract][Full Text] [Related]
34. Entry of Polarized Effector Cells into Quiescence Forces HIV Latency. Dobrowolski C; Valadkhan S; Graham AC; Shukla M; Ciuffi A; Telenti A; Karn J mBio; 2019 Mar; 10(2):. PubMed ID: 30914509 [TBL] [Abstract][Full Text] [Related]